Danny Cabrera on BioBots and the Future of 3D Bioprinting

BioBots is a recently formed 3D bioprinting company that uses 3D printing technology to print living tissues into any shape.

Measured at just 12 inches squared, this little desktop bioprinter has numerous applications depending on the type of Bio-Ink used which consist of different mixtures of cells and bio-compatible materials.

Danny Cabrera, the Co-founder and CEO of BioBots, believes with the arrival of this new technology, he hopes this can become a huge stepping stone in the advancement of modern health and medicine. Danny joined us on The Spotlight this week to talk about the evolution of his company, what the technology entails, how the device is operated, as well as the direction his team wants to take this revolutionary tool in the coming years and beyond.

Read the full article here.

Previous

Next